Fw. May et al., Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs, MED J AUST, 170(10), 1999, pp. 471-474
Citations number
25
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Objective: Exploration of longer-term outcomes of an ongoing educational-ou
treach service for community doctors.
Design: Quasi-experimental, with parallel and historical comparisons.
Setting: Since 1992, a teaching-hospital-based service has been providing a
dvice and information on drugs and therapeutic strategies to community medi
cal practitioners.
Participants: 210 doctors practising in a particular area of metropolitan A
delaide (79% general practitioners; 21% specialists).
Interventions: Two surgery visits during 1992 focused on better use of pres
cribed non-steroidal anti-Inflammatory drugs (NSAIDs). Subsequent visits on
other topical therapeutic issues have occurred regularly.
Main outcome measures: Doctor participation in the service; supply of presc
ription NSAIDs; hospital admissions for gastrointestinal (GI) effects of NS
AID use.
Results: 89% of doctors practising within the service area received the fir
st visit on NSAIDs and 86% received the second visit. More than 85% continu
e to receive the service. Relative to a comparison area, aggregate reductio
ns of 9% and 28%, respectively, were observed in two different measures of
NSAID use. During an Ii-year observation period, a single change point in t
he number of hospital admissions for GI disorders occurred in the service a
rea, coinciding with delivery of the NSAID program. In the five years since
the visits commenced, a 70% reduction in admissions was observed. No notab
le changes in hospital admission rates occurred in the comparison area.
Conclusions: A continuing education and support service for community medic
al practitioners which uses principally academic detailing methods in its c
ontact with doctors has contributed to sustained changes in prescribed NSAI
D use over a five-year period. A focus on risk-minimisation in prescribing
of NSAIDs appears to have contributed to reductions in hospitalisations for
GI adverse events.